Cargando…

Low Complement Factor H-Related 3 (CFHR3) Expression Indicates Poor Prognosis and Immune Regulation in Cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma (CCA) is a cancerous tumor that leads to a high rate of morbidity and death. Complement factor H-related 3 (CFHR3) is a gene belonging to the CFHR gene family. In this study, we investigated the usefulness of CFHR3 in the diagnostic stage and CCA prognosis prediction....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haoran, He, Meng, Zhang, Zheng, Yin, Wenze, Ren, Bixuan, Lin, Yujia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546675/ https://www.ncbi.nlm.nih.gov/pubmed/36213819 http://dx.doi.org/10.1155/2022/1752827

Ejemplares similares

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
por: Zipfel, Peter F, et al.
Publicado: (2007)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi
por: Siegel, Corinna, et al.
Publicado: (2010)

Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3
por: Pouw, Richard B., et al.
Publicado: (2016)

Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
por: Holmes, Lucy V., et al.
Publicado: (2013)

Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions
por: Hannan, Jonathan P., et al.
Publicado: (2016)

Human Factor H-Related Protein 2 (CFHR2) Regulates Complement Activation
por: Eberhardt, Hannes U., et al.
Publicado: (2013)

Regulating complement in the kidney: insights from CFHR5 nephropathy
por: Gale, Daniel P., et al.
Publicado: (2011)

Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome
por: Jiang, Hong, et al.
Publicado: (2016)

Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population
por: Gan, Wei, et al.
Publicado: (2012)

High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B
por: Pouw, Richard B., et al.
Publicado: (2018)

Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis
por: Sugawara, Yuka, et al.
Publicado: (2019)

Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
por: Diep, Jason, et al.
Publicado: (2023)

Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of CFHR4
por: Pouw, Richard B., et al.
Publicado: (2018)

Corrigendum: High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3(*)B
por: Pouw, Richard B., et al.
Publicado: (2020)

Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade
por: Bitzan, Martin, et al.
Publicado: (2018)

Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration
por: Narendra, Umadevi, et al.
Publicado: (2009)

Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations
por: Kumar, Vikrant, et al.
Publicado: (2022)

Pathogenic Neisseria Bind the Complement Protein CFHR5 via Outer Membrane Porins
por: Yee, Wearn-Xin, et al.
Publicado: (2022)

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma
por: Liang, Zhanqiang, et al.
Publicado: (2019)

Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
por: Wu, Qiao, et al.
Publicado: (2020)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2021)

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma
por: Yu, Hongjun, et al.
Publicado: (2022)

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Huang, Yu, et al.
Publicado: (2018)

CFHR1 is a potentially downregulated gene in lung adenocarcinoma
por: Wu, Geting, et al.
Publicado: (2019)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma
por: Wei, Jie, et al.
Publicado: (2022)

Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy
por: Ishii, Norihiro, et al.
Publicado: (2017)

Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis
por: Augusto, Jean-François, et al.
Publicado: (2016)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
por: Piras, Rossella, et al.
Publicado: (2021)

The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma
por: Wan, Zhongzhong, et al.
Publicado: (2022)

IL23R as an indicator of immune infiltration and poor prognosis in intrahepatic cholangiocarcinoma: a bioinformatics analysis
por: Zhang, Lin-Ting, et al.
Publicado: (2023)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Correction for: The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma
por: Wan, Zhongzhong, et al.
Publicado: (2022)

Low Serum Levels of Complement C3c at Diagnosis Indicate Poor Outcome in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
por: Tampe, Désirée, et al.
Publicado: (2022)

Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma
por: Wang, Ziming, et al.
Publicado: (2020)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h3t72m6b9bcm9a15hlonfna6di